As in mice, longitudinal immune monitoring in patients with MM, provided evidence that high butyrate was associated with less accumulation of memory and less ICOS induction on T cells in hosts with cancer and treated with anti-CTLA-4. Here, CTLA4 is linked to Miyoshi myopathy.